Ixekizumab was more effective for the treatment of mild to moderate psoriasis vs severe psoriasis at most time points through 52 weeks.

Patients with prescriptions can buy low-dose Ozempic and Wegovy for $199 per month for 2 months from now until March.

HealthDay News — A Washington state resident has become the first person in the United States to test positive for a rare bird flu strain that has never before been found in humans. The older adult, ...

HealthDay News — More than one in eight U.S. teens and young adults use generative artificial intelligence (AI) for mental health advice, according to a research letter published online Nov. 7 in JAMA ...

In both studies, upadacitinib met the coprimary endpoints of T-VASI 50 and F-VASI 75 at week 48 vs placebo. Topline data were announced from 2 replicate phase 3 studies evaluating upadacitinib in ...

A family history of malignancy is the only patient-specific factor associated with a significantly increased risk for cancer among patients with psoriatic disease treated with biologics vs topical ...

Despite having greater rates of cardiometabolic risk factors and atherosclerotic cardiovascular disease risk, less than a quarter of patients with severe hidradenitis suppurativa are meeting treatment ...

Rule out melanoma terminology used on pathology requisition forms is frequently used for lesions that are low-risk and has a relatively low positive predictive value for a melanoma diagnosis. The use ...

Findings showed cemiplimab reduced the risk of disease recurrence or death by 68% compared with placebo. The Food and Drug Administration (FDA) has approved Libtayo ® (cemiplimab-rwlc) for the ...

The product is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Bondlido ® (lidocaine topical system 10%) for the relief of pain associated with ...

In addition to an overall elevated infection risk, patients receiving adalimumab with hidradenitis suppurativa have a greater risk for sepsis and genitourinary infections than those with psoriasis.

The recommended dosage for active PsA and moderate to severe plaque PsO in pediatric patients 6 years (≥40kg) is 100mg administered SC at week 0, 4, and then every 8 weeks thereafter. The approval for ...